Cairo – Mubasher: Ibnsina Pharma announced that the company’s shareholders had approved distributing a cash dividend of EGP 0.070 a share with a total value of EGP 50.89 million for 2018 during an ordinary general meeting (OGM).

The OGM also approved distributing 98 million bonus shares, or 0.136 bonus share per each share, at a total value of EGP 24.5 million, according to a statement on Sunday.

The company’s capital reaches EGP 180.5 million distributed over 722 million shares.

Moreover, the Egyptian firm’s extraordinary general meeting (EGM) approved raising the company’s issued capital by SAR 24.5 million to SAR 205 million financed from profits.

For the full-year 2018, Ibnsina Pharma logged a profit of EGP 262.52 million, compared to EGP 170.13 million in the prior year.

In addition, revenues increased to EGP 13.6 billion last year from EGP 9.8 billion in 2017.